TY - JOUR
T1 - Long-term effects of asparaginase-associated pancreatitis
AU - Skipper, Mette Tiedemann
AU - Albertsen, Birgitte Klug
AU - Schmiegelow, Kjeld
AU - Andrés-Jensen, Liv
N1 - © 2023 The Authors. Pediatric Blood & Cancer published by Wiley Periodicals LLC.
PY - 2023
Y1 - 2023
N2 - Pancreatitis is a common and severe toxicity that occurs during asparaginase treatment for acute lymphoblastic leukemia, and has received increasing attention during the last decades. However, no consensus regarding follow-up exists. In this commentary, we highlight potential long-term health-related effects following asparaginase-associated pancreatitis, thereby providing clinicians with a framework when following these patients during and after cessation of therapy.
AB - Pancreatitis is a common and severe toxicity that occurs during asparaginase treatment for acute lymphoblastic leukemia, and has received increasing attention during the last decades. However, no consensus regarding follow-up exists. In this commentary, we highlight potential long-term health-related effects following asparaginase-associated pancreatitis, thereby providing clinicians with a framework when following these patients during and after cessation of therapy.
KW - ALL
KW - chemotherapy
KW - late effects of cancer treatment
KW - long-term survival
KW - pediatric hematology/oncology
UR - http://www.scopus.com/inward/record.url?scp=85163303452&partnerID=8YFLogxK
U2 - 10.1002/pbc.30528
DO - 10.1002/pbc.30528
M3 - Comment/debate
C2 - 37376950
SN - 1545-5009
VL - 70
JO - Pediatric Blood & Cancer
JF - Pediatric Blood & Cancer
IS - 9
M1 - e30528
ER -